Detalhe da pesquisa
1.
Evaluation of the interest to combine a CD4 Th1-inducer cancer vaccine derived from telomerase and atezolizumab plus bevacizumab in unresectable hepatocellular carcinoma: a randomized non-comparative phase II study (TERTIO - PRODIGE 82).
BMC Cancer
; 23(1): 710, 2023 Jul 29.
Artigo
em Inglês
| MEDLINE | ID: mdl-37516867
2.
Impact of COVID-19 on the management of hepatocellular carcinoma in a high-prevalence area: What's new 12 months later?
Ann Hepatol
; 28(6): 101141, 2023 Jul 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-37468096
3.
Artificial intelligence predicts immune and inflammatory gene signatures directly from hepatocellular carcinoma histology.
J Hepatol
; 77(1): 116-127, 2022 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-35143898
4.
Utility of Early Posttreatment PET/CT Evaluation Using FDG or 18F-FCH to Predict Response to 90Y Radioembolization in Patients With Hepatocellular Carcinoma.
AJR Am J Roentgenol
; 218(2): 359-369, 2022 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-34494448
5.
Liver resection for single large hepatocellular carcinoma: a prognostic factors study.
Ann Hepatol
; 27(6): 100739, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-35781089
6.
Regorafenib Efficacy After Sorafenib in Patients With Recurrent Hepatocellular Carcinoma After Liver Transplantation: A Retrospective Study.
Liver Transpl
; 27(12): 1767-1778, 2021 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-34388851
7.
Predicting Survival After Hepatocellular Carcinoma Resection Using Deep Learning on Histological Slides.
Hepatology
; 72(6): 2000-2013, 2020 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-32108950
8.
Multiphase Liver MRI for Identifying the Macrotrabecular-Massive Subtype of Hepatocellular Carcinoma.
Radiology
; 295(3): 562-571, 2020 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-32228294
9.
Intrahepatic immune changes after hepatitis c virus eradication by direct-acting antiviral therapy.
Liver Int
; 40(1): 74-82, 2020 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-31444947
10.
Hepatobiliary MR contrast agent uptake as a predictive biomarker of aggressive features on pathology and reduced recurrence-free survival in resectable hepatocellular carcinoma: comparison with dual-tracer 18F-FDG and 18F-FCH PET/CT.
Eur Radiol
; 30(10): 5348-5357, 2020 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-32405753
11.
Preliminary experience on safety of regorafenib after sorafenib failure in recurrent hepatocellular carcinoma after liver transplantation.
Am J Transplant
; 19(11): 3176-3184, 2019 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-31365177
12.
Gemcitabine and oxaliplatin chemotherapy for advanced hepatocellular carcinoma after failure of anti-angiogenic therapies.
Invest New Drugs
; 32(5): 1028-35, 2014 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-24748335
13.
Atezolizumab and bevacizumab for non-resectable or metastatic combined hepatocellular-cholangiocarcinoma: A multicentric retrospective study.
United European Gastroenterol J
; 2023 Dec 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-38059651
14.
TACE and conformal radiotherapy vs. TACE alone for hepatocellular carcinoma: A randomised controlled trial.
JHEP Rep
; 5(4): 100689, 2023 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-36937990
15.
Macrotrabecular-Massive Hepatocellular Carcinoma: Light and Shadow in Current Knowledge.
J Hepatocell Carcinoma
; 9: 661-670, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-35923611
16.
Impact of Extended Use of Ablation Techniques in Cirrhotic Patients with Hepatocellular Carcinoma: A Cost-Effectiveness Analysis.
Cancers (Basel)
; 14(11)2022 May 26.
Artigo
em Inglês
| MEDLINE | ID: mdl-35681618
17.
Evaluating the Effectiveness of Yttrium-90 Glass Microspheres in the Treatment of Hepatocellular Carcinoma, Intrahepatic Cholangiocarcinoma, and Metastatic Colorectal Cancer in Practice: Protocol for the Prospective PROACTIF Phase IV Registry Study in France.
Cardiovasc Intervent Radiol
; 45(1): 1-11, 2022 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-34796373
18.
Systemic Treatments with Tyrosine Kinase Inhibitor and Platinum-Based Chemotherapy in Patients with Unresectable or Metastatic Hepatocholangiocarcinoma.
Liver Cancer
; 11(5): 460-473, 2022 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-36158591
19.
Immune Profiling of Combined Hepatocellular- Cholangiocarcinoma Reveals Distinct Subtypes and Activation of Gene Signatures Predictive of Response to Immunotherapy.
Clin Cancer Res
; 28(3): 540-551, 2022 02 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-34785581
20.
Personalised versus standard dosimetry approach of selective internal radiation therapy in patients with locally advanced hepatocellular carcinoma (DOSISPHERE-01): a randomised, multicentre, open-label phase 2 trial.
Lancet Gastroenterol Hepatol
; 6(1): 17-29, 2021 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-33166497